Advertisement

Topics

Search Results for "Smecta "

17:16 EDT 1st May 2016 | BioPortfolio

Matching Channels

None

Matching News

BRIEF-Ipsen reports Q3 group sales up 5.2 pct at 354.5 mln euros

* In Q3, sales primary care products reached 78.9 million euros, down 5.0 pct year-on-year, affected by sales decline of Smecta in China and of Tanakan in Russia

Ipsen: sales in the 3rd quarter and first nine months of 2015

Group sales up 5.2%1 in the third quarter Specialty care sales up 8.6%1, driven by Somatuline® growth in neuroendocrine tumors ...

Ipsen’s 2015 Results and 2016 Financial Objectives

Operating performance in line with guidance, with Group sales up 10.4%1 and Core Operating Income up 23.8% Core diluted EPS of €2.78, up 25.3%, and sou...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement